Targeted Inhibition of the Epidermal Growth Factor Receptor and Mammalian Target of Rapamycin Signaling Pathways in Olmsted Syndrome

Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology

Use of Epidermal Growth Factor Receptor Inhibitor Erlotinib to Treat Palmoplantar Keratoderma in Patients With Olmsted Syndrome Caused by TRPV3 Mutations

JAMA Dermatol.

Greco C, Leclerc-Mercier S, Chaumon S, Doz F, Hadj-Rabia S, Molina T, Boucheix C, Bodemer C

doi: 10.1001/jamadermatol.2019.4126.

Osteoarthritis

Fibroblast growth factor signalling in osteoarthritis and cartilage repair

Nat Rev Rheumatol.

Xie Y, Zinkle A, Chen L, Mohammadi M

doi: 10.1038/s41584-020-0469-2.

Further Publications Dermatology

Tumor necrosis factor receptor-1 assciated periodic syndrome (TRAPS) related AA amyloidosis: a national case series and systematic review

Rheumatology (Oxford)

Delaleu J, Deshayes S, Rodrigues F, Savey L, Rivière E, Martin Silva N, Aouba A, Amselem S, Rabant M, Grateau G, Giurgea I, Georgin-Lavialle S

doi: 10.1093/rheumatology/keab252

Further Publications Rheumatology

Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trial

Ann Rheum Dis

Felten R, Devauchelle-Pensec V, Seror R, Duffau P, Saadoun D, Hachulla E, Pierre Yves H, Salliot C, Perdriger A, Morel J, Mékinian A, Vittecoq O, Berthelot JM, Dernis E, Le Guern V, Dieudé P, Larroche C, Richez C, Martin T, Zarnitsky C, Blaison G, Kieffer P, Maurier F, Dellal A, Rist S, Andres E, Contis A, Chatelus E, Sordet C, Sibilia J, Arnold C, Tawk MY, Aberkane O, Holterbach L, Cacoub P, Saraux A, Mariette X, Meyer N, Gottenberg JE

doi: 10.1136/annrheumdis-2020-218467

Rheumatoid Arthritis

Platelet-rich plasma inhibits inflammatory factors and represses rheumatoid fibroblast-like synoviocytes in rheumatoid arthritis.

Clin Exp Med.

Tong S, Liu J, Zhang C

doi: 10.1007/s10238-017-0449-2.

Autoimmune Disease

The Nrf2-Antioxidant Response Element Signaling Pathway Controls Fibrosis and Autoimmunity in Scleroderma

Front Immunol.

Kavian N, Mehlal S, Jeljeli M, Saidu NEB, Nicco C, Cerles O, Chouzenoux S, Cauvet A, Camus C, Ait-Djoudi M, Chéreau C, Kerdine-Römer S, Allanore Y, Batteux F

doi: 10.3389/fimmu.2018.01896.

Autoimmune DiseaseT Cells

A comprehensive review on the role of co-signaling receptors and Treg homeostasis in autoimmunity and tumor immunity

J Autoimmun.

Kumar P, Bhattacharya P, Prabhakar BS

doi: 10.1016/j.jaut.2018.08.007.

Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology

A national consensus management pathway for paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): results of a national Delphi process

Lancet Child Adolesc Health.

Harwood R, Allin B, Jones CE, Whittaker E, Ramnarayan P, Ramanan AV, Kaleem M, Tulloh R, Peters MJ, Almond S, Davis PJ, Levin M, Tometzki A, Faust SN, Knight M, Kenny S, PIMS-TS National Consensus Management Study Group.

doi: 10.1016/S2352-4642(20)30304-7.

Systemic Immunomodulating Therapies for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Systematic Review and Meta-analysis